Sheila Oren, MD MBA

Commander
DISC Type : D

Healthtech Community leader at Next October

Herzliya, Tel Aviv District, Israel

Overview

Sheila Oren is a healthtech executive with over 25 years of experience leading drug and device development, particularly for neurological conditions. A co-founder and CEO, she has held senior roles at Teva, NeuroDerm, and Remepy, bringing a major Parkinsons drug from Phase 1 to market. She holds an MD from Tel Aviv University and an MBA from Reichman University.

Beyond her corporate roles, Sheila is a mentor and community leader dedicated to social impact through innovation. She leads the healthtech community for Next October, an initiative harnessing Israeli technology to honor victims of the October 2023 Hamas War. She is also an active member of the 8400 healthtech leadership network.

She played a pivotal role in NeuroDerms successful NASDAQ IPO and its subsequent acquisition by Mitsubishi Tanabe for $1. 1 billion.

Personality Overview

Decisive

Risk-Taker

Very Quick

They prefer to move quickly, and expect the same from others.  They put a lot of effort into ensuring personal success. They do not care very much about building rapport or relationships.

Topics They Care About

Parkinson's Disease
Her career has been dedicated to this area, from leading the market launch of the drug AZILECT to her current role as Chief Parkinson’s Program Officer at Remepy.
Drug Development
Has extensive experience taking new drugs from initial clinical trials all the way to market launch, with expertise in clinical and regulatory strategy.
HealthTech Innovation
Her current work involves digital therapeutics and hybrid treatments, reflecting a focus on leveraging technology to create the next generation of medicine.

Media Appearances

Sheila has no verified media appearances

Work History

9-2024
Healthtech Community leader at Next October
4-2024
Chief Parkinson’s Program Officer at Remepy
8-2020
Senior Medical Advisor at SOREN Medical Consulting
11-2023 - 5-2024
Co-founder & CEO @ Anabasis at Anabasis LTD
1-2021 - 4-2023
Chief Executive Officer at Pharma Two B

Education

1980 - 1988
Doctor of Medicine (MD) from School of Medicine, Tel Aviv University, Israel
2008 - 2009
MBA from Reichman University

More Information

Social Presence :

Prographics :

Exp : 4 Location : Herzliya, Tel Aviv District, Israel Job Level : Junior Designation : Healthtech Community leader at Next October
URL has been copied!

Insights For Selling To Sheila

During A Call Or A Meeting

DO's

  • Speak about competitive differentiation that your product offers
  • Objectively showcase the impact that your product creates
  • Hold your ground without indulging in one-upmanship

DONT's

  • Don’t focus on process and rules, give the impression of being a ‘gets it done’ person
  • Don't try too hard to forge relationships with them
  • Don’t be in a rush to invite them for a social meet and greet

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Sheila is

  • Confidence in impact is paramount to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Sheila

  • If they are not convinced, they will have no hesitation in telling you the same.

Insights For Deal Planning

    How fast (or slow) will Sheila move?

  • If convinced, they can reach decisions quite fast.
  • Can Sheila take some risk or not?

  • They do not shy away from taking risks, but can be quite binary about them.

You And Sheila

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.